SKYE - Rega marang dodolan skyebioscience.com

Skye Bioscience, Inc. (SKYE) is developing unique treatments for metabolic and ocular pathologies, which will ensure high therapy pricing power. The historical P/S ratio confirms market expectations for these innovations. captures the current state of the parameter. Growth prospects rely on scalable molecule synthesis with low variable costs and robust diversification of raw material supply chains to eliminate logistical disruptions.

SKYE Kapitalisasi marang pendapatan Skye Bioscience Inc. (04.07.2022 - 14.11.2026)

Rincian analitis perusahaan Skye Bioscience, Inc. (SKYE)

- nilai saham lan prakiraan konsensus rega:

Rega saham Skye Bioscience Inc.|SKYE - Target konsensus

- statistik kapitalisasi pasar:

Nilai pasar Skye Bioscience|SKYE - Nilai Perusahaan

- data nilai buku modal saham:

Nilai Aset Bersih saben Saham Skye Bioscience|SKYE - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku skyebioscience.com|SKYE - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Utang marang Ekuitas Skye Bioscience, Inc.|SKYE - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal skyebioscience.com|SKYE - Utang perusahaan|Utang-utang marang nilai buku Skye Bioscience|SKYE - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Skye Bioscience|Indikator likuiditas cepet skyebioscience.com

- data bathi lan kelipatan valuasi:

SKYE - Bathi resik|Prakiraan bathi perusahaan Skye Bioscience, Inc.|SKYE - Pangali P/E|Rasio prakiraan rega marang bathi Skye Bioscience Inc.|SKYE - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Skye Bioscience|SKYE - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Skye Bioscience|SKYE - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan skyebioscience.com|SKYE - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Skye Bioscience, Inc.

- indikator pendapatan dodolan lan penghasilan bisnis:

SKYE - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan skyebioscience.com|SKYE - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Skye Bioscience

Analisis fundamental perusahaan:SKYE - Skye Bioscience Inc.

For Skye Bioscience, Inc. (SKYE), the distribution efficiency of bioactive substances directly impacts revenue, making the price/sales ratio a key tool for valuing the business relative to its operating income. This indicator compares market capitalization with annual turnover, allowing an analysis of the chart to determine asset overvaluation and the risk of a capital correction when quotes deviate from historical averages.

Pesaing Skye Bioscience, Inc.

Multiplikator P/S indivior.com (INDV)|Collegium Pharmaceutical, Inc. - Kapitalisasi marang pendapatan|Cronos Group Inc (CRON) - Rega marang dodolan|Tweed - Multiplikator P/S|Rega marang dodolan Canna Cabana|ACB (auroramj.com) - Kapitalisasi marang pendapatan|achievelifesciences.com - Rasio kapitalisasi pasar marang pendapatan|ANEB (Anebulo Pharmaceuticals, Inc.) - Multiplikator P/S|Rasio rega marang pendapatan INCR|Multiplikator P/S NTRB|Koefisien rega marang pendapatan nasuspharma.com|Rasio rega marang pendapatan IGC Pharma IGC|MIRA Pharmaceuticals Inc. (MIRA) - Rega marang dodolan|FLGC - Rasio rega marang pendapatan|Koefisien rega marang pendapatan IM Cannabis Corp. IMCC|ADIL: Multiplikator P/S|Kapitalisasi marang pendapatan Artelo Biosciences, Inc.|ENSC (Ensysce Biosciences Inc.) - Multiplikator P/S|Titan Pharma (TTNP) - Koefisien rega marang pendapatan|Multiplikator P/S GNLN|INM - Rega marang dodolan|Rasio rega marang pendapatan Akanda Corporation AKAN|ENVB: Rasio kapitalisasi marang pendapatan|Bright Green Corp - Multiplikator P/S|Hempacco Co Inc. (HPCO) - Kapitalisasi marang pendapatan